Cirina
New York
About Cirina
Cirina is developing innovative blood-plasma tests to detect deadly diseases at their earliest stages when curative treatments are most viable. The company is driven by the passion and life-long work of Co-founder and plasma nucleic acid pioneer, Dennis Lo, the first scientist to discover the presence of fetal DNA in a pregnant mother’s blood-plasma. Headquartered in South San Francisco, Calif., Cirina is currently actively recruiting top scientific and business talent to join its quest to detect devastating diseases like cancer at their earliest stages and empower people to take action. For more information, please visit http://cirinalabs.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2016)
- Website: cirina.com
- Phone: 415) 722-2129
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cirina-22012 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.